Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000195602 | SCV000250221 | uncertain significance | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Invitae | RCV000233352 | SCV000287267 | likely benign | Congenital contractural arachnodactyly | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000233352 | SCV000781464 | uncertain significance | Congenital contractural arachnodactyly | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345705 | SCV002647208 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-05-23 | criteria provided, single submitter | clinical testing | The p.V1768A variant (also known as c.5303T>C), located in coding exon 41 of the FBN2 gene, results from a T to C substitution at nucleotide position 5303. The valine at codon 1768 is replaced by alanine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV000195602 | SCV004159322 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | FBN2: BS1 |